High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression

J Allergy Clin Immunol. 2022 Jan;149(1):135-144.e12. doi: 10.1016/j.jaci.2021.05.027. Epub 2021 Jun 1.

Abstract

Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease presenting with diverse manifestations ranging from nodules and abscesses to draining tunnels. Whether the underlying inflammation from lesions extends to relatively healthy-appearing adjacent perilesional and distant nonlesional skin has not been systematically evaluated.

Objective: We sought to characterize lesional, perilesional, and nonlesional skin in patients with HS.

Methods: Skin biopsy samples were collected under ultrasound guidance from patients with active, untreated moderate-to-severe HS. Site-matched control biopsy samples from healthy volunteers were used for comparison.

Results: RNA sequencing demonstrated that HS skin clustered separately from healthy control skin, with perilesional and lesion skin clustering together and away from nonlesional skin. Immunohistochemistry analysis identified psoriasiform hyperplasia with keratin 16 positivity in both perilesional and lesional skin, with comparable levels of CD3+, CD11c+, and neutrophil elastase-positive cellular infiltration. There was a marked upregulation of IL-17 signaling in perilesional and lesional skin. HS samples clustered on the basis of expression of lipocalin-2 (LCN2), with samples characterized by high LCN2 expression in the skin exhibiting a differing transcriptomic profile with significantly higher overall inflammation than that of skin characterized by low LCN2 levels.

Conclusions: Perilesional HS skin has a transcriptomic and molecular profile comparable to that of lesional skin. HS can be grouped into 2 distinct subtypes based on molecular levels of LCN2 in the skin, with the LCN2-high subtype exhibiting an overall higher inflammatory burden and an upregulation of targetable cytokines. To our knowledge, this is the first study to characterize a unique HS subtype (and a potential endotype) that may guide future therapeutic targets.

Keywords: Hidradenitis suppurativa; IL-17 signaling; lesional; lipocalin-2; neutrophils; nonlesional; perilesional.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Clinical Trials as Topic
  • Female
  • Hidradenitis Suppurativa / diagnostic imaging
  • Hidradenitis Suppurativa / genetics
  • Hidradenitis Suppurativa / immunology*
  • Hidradenitis Suppurativa / pathology
  • Humans
  • Inflammation / diagnostic imaging
  • Inflammation / genetics
  • Inflammation / immunology
  • Inflammation / pathology
  • Interleukin-17 / immunology
  • Lipocalin-2 / immunology*
  • Male
  • Middle Aged
  • Phenotype
  • Skin / diagnostic imaging
  • Skin / immunology*
  • Skin / pathology
  • Transcriptome
  • Ultrasonography, Doppler
  • Young Adult

Substances

  • Interleukin-17
  • LCN2 protein, human
  • Lipocalin-2